Myeloid leukemia: Disease genes and mouse models

Progress in Experimental Tumor Research

Volumn 35, Issue , 1999, Pages 53-63

  Copeland, Neal G ^a   Jenkins, Nancy A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN; MOUSE; MOUSE STRAIN; MYELOID LEUKEMIA; ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; DISEASE MODELS, ANIMAL; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOID; MICE; MICE, INBRED STRAINS; ONCOGENES;

EID: 0032605729     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000062003     Document Type: Article

References (35)

1. Bedigian HG, Taylor BA, Meier H: Expression of murine leukemia viruses in the highly lymphomatous BXH2 recombinant inbred mouse strain. J Virol 1981;39:632-640.
2. Bedigian HG, Johnson DA, Jenkins NA, Copeland NG, Evans R: Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice. J Virol 1984;51:586-594.
3. Jenkins NA, Copeland NG, Taylor BA, Bedigian HG, Lee BK: Ecotropic murine leukemia virus DNA content of normal and lymphomatous tissues of BXH2 recombinant inbred mice. J Virol 1982;42:379-388.
4. Bedigian HG, Shepel LA, Hoppe PC: Transplacental transmission of a leukemogenic murine leukemia virus. J Virol 1993;67:6105-6109.
5. Buchberg AM, Bedigian HG, Jenkins NA, Copeland NG: Evi2, a common integration site involved in murine myeloid leukemogenesis. Mol Cell Biol 1990;10:4658-4666.
6. Cawthon RM, Andersen LB, Buchberg AM, Xu G, O'Connel P, Viskochil D, Weiss RB, Wallace MR, Marchuk DA, Culver M, Stevens J, Jenkins NA, Copeland NG, Collins FS, White R: cDNA sequence and genomic structure of EVI-2B, a gene lying within an intron of the neurofibromatosis type 1 gene. Genomics 1991;9:446-460.
7. Largaespada DA, Shaughnessy JD Jr, Jenkins NA, Copeland NG: Retroviral integration at the Evi2 locus in BXH2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels. J Virol 1995;69:5095-5102.
8. Bader JL, Miller RW: Neurofibromatosis and childhood leukemia. J Pediatr 1978;92:925-929.
9. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F: Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 1994;330:579-601.
10. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, Buchberg AM, Jenkins NA, Parada LF, Copeland NG: Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994;8: 1019-1029.
11. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 1994;7:353-361.
12. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG: Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukemia. Nat Genet 1996;12:137-143.
13. Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedamn MH, McCormick F, Jacks T, Shannon K: Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 1996;12:144-148.
14. Wolf L: Myb-induced transformation. Crit Rev Oncog 1996;7:245-260.
15. Nakamura T, Largaespada DA, Shaughnessy JD, Jenkins NA, Copeland NG: Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. Nat Genet 1996;12:149-153.
16. Moskow JJ, Bullrich F, Huebner K, Daar IO, Buchberg AM: Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice. Mol Cell Biol 1995;15:5434-5443.
17. Kamps MP, Murre C, Sun X, Baltimore D: A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990;60:547-555.
18. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML: Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990;60:534-545.
19. Monica K, Galili N, Nourse J, Saltman D, Cleary ML: PBX2 and PBX3, new homeobox genes with extensive homology to the human protooncogene PBX1. Mol Cell Biol 1991;11:6149-6157.
20. Lawrence HJ, Sauvageau G, Humphries RK, Largman C: The role of HOX homeobox genes in normal and leukemic hematopoiesis. Stem Cells 1996;14:281-291.
21. Lawrence HJ, Helgason CD, Sauvageau G, Fong S, Izon DJ, Humphries RK, Largman C: Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 1997;89:1922-1930.
22. Thorsteinsdottir U, Sauvageau G, Humphries RK: Hox homeobox genes as regulators of normal and leukemic hematopoiesis. Hematol Oncol Clin North Am 1997;11:1221-1237.
23. Shen W-F, Montgomery JC, Rozenfeld S, Moskow JJ, Lawrence HJ, Buchberg AM, Largman C: AbdB-like Hox proteins stabilize DNA binding by the Meisl homeodomain proteins. Mol Cell Biol 1997;17:6448-6458.
24. Nakamura T, Jenkins NA, Copeland NG: Identification of a new family of Pbx-related homeobox genes. Oncogene 1996;13:2235-2242.
25. Steelman S, Moskow JJ, Muzynski K, North C, Druck T, Montgomery JC, Huebner K, Daar IO, Buchberg AM: Identification of a conserved family of Meis1-related homeobox genes. Genome Res 1997;7:142-156.
26. Chen H, Rossier C, Nakamura Y, Lynn A, Chakravarti A, Antonarakis SE: Cloning of a novel homeobox-containing gene, PKNOX1, and mapping to human chromosome 21q22.3. Genomics 1997;41:193-200.
27. Chang C-P, Jacobs Y, Nakamura T, Jenkins NA, Copeland NG, Cleary ML: Meis proteins are major in vivo DNA binding partners for wildtype but not chimeric Pbx proteins. Mol Cell Biol 1997;17:5679-5687.
28. Bertolino E, Reimund B, Wildt-Perinic D, Clerc RC: A novel homeobox protein which recognizes a TGT core and functionally interferes with a retinoid-responsive motif. J Biol Chem 1995;52: 31178-31188.
29. Knoepfler PS, Calvo KR, Chen H, Antonarakis SE: Mesil and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc Natl Acad Sci USA 1997;94:14553-14558.
30. Rieckhof GE, Casares F, Ryoo HD, Abu-Shaar M, Mann RS: Nuclear translocation of extradenticle requires homothorax, which encodes an extradenticle-related homeodomain protein. Cell 1997;91: 171-183.
31. Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen I-M, Feinberg AP, Jenkins NA, Copeland NG, Shaughnessy JD: Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet 1996;12:154-158.
32. Borrow J, Shearman AM, Stanton VP, Becher R, Collins T, Williams AJ, Dubé I, Katz F, Kwong YL, Morris C, Ohyashiki K, Toyama K, Rowley J, Housman DE: The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet 1996;12:159-167.
33. von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A, Grosveld G: The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 1992;12:1687-1697.
34. Kraemer D, Wozniak RW, Blobel G, Radu A: The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm. Proc Natl Acad Sci USA 1994;91:1519-1523.
35. Look TA: Oncogenic transcription factors in the human acute leukemias. Science 1997;278:1059-1064.